Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage MIMS Class ATC Classification Regulatory Classification Presentation/Packing Brand Resources

Full Prescribing Info

Indications/Uses

NUBEQA is indicated for the treatment of adult men with: non-metastatic castration resistant prostate cancer (nmCRPC) who are at high risk of developing metastatic disease (see Pharmacology: Pharmacodynamics under Actions); metastatic hormone-sensitive prostate cancer (mHSPC) in combination with docetaxel and androgen deprivation therapy (see Pharmacology: Pharmacodynamics under Actions).

Nubeqa Indications/Uses

darolutamide

Manufacturer:

Bayer

Distributor:

Zuellig